Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed COO
RenovoRx, Inc. (RNXT) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/04/2023 4 Nelms Angela (COO) has filed a Form 4 on RenovoRx, Inc.
Txns: Bought 300 shares @ $1.0499, valued at $315
Bought 800 shares @ $1.045, valued at $836
10/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/25/2023 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
08/17/2023 8-K Quarterly results
Docs: "RenovoRx Reports Second Quarter 2023 Financial Results and Operational Highlights"
08/16/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/15/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
06/29/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
06/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/19/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/15/2023 8-K Quarterly results
Docs: "RenovoRx Reports First Quarter 2023 Financial Results and Operational Highlights"
05/12/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
05/12/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/01/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/27/2023 4 Spiegel Robert J. (Director) has filed a Form 4 on RenovoRx, Inc.
Txns: Granted 43,026 options to buy @ $2.74, valued at $117.9k
04/27/2023 3 Spiegel Robert J. (Director) has filed a Form 3 on RenovoRx, Inc.
04/27/2023 8-K Quarterly results
04/03/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Financial Statements and E...
Docs: "PREFUNDED COMMON STOCK PURCHASE WARRANT RenovoRx, Inc. Warrant Shares: _______ Initial Exercise Date: April __, 2023 THIS PREFUNDED COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof until this Warrant is exercised in full but not thereafter, to subscribe for and purchase from RenovoRx, Inc., a Delaware corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . In addition to the terms defined elsewhere in this Warrant, the following terms have the me...",
"COMMON STOCK PURCHASE WARRANT RenovoRx, Inc. Warrant Shares: _______ Initial Exercise Date: April ____, 2023 Issue Date: April ____, 2023 THIS COMMON STOCK PURCHASE WARRANT certifies that, for value received, _____________ or its assigns is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after April ____, 2023 and on or prior to 5:00 p.m. on October ____, 2028 1 but not thereafter, to subscribe for and purchase from RenovoRx, Inc., a Delaware corporation , up to ______ shares of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2. Section 1 . Definitions . Capitalized terms used and not otherwise defined herein shall have...",
"Re: Registration Statement on Form S-3",
"PLACEMENT AGENCY AGREEMENT",
"SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement is dated as of March 30, 2023, between RenovoRx, Inc., a Delaware corporation , and each purchaser identified on the signature pages hereto . WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an effective registration statement under the Securities Act as to the Shares and Pre-Funded Warrants and an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4 thereof and/or Regulation D thereunder as to the Common Warrants, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement. NOW, THEREFORE,...",
"RenovoRx, Inc. Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules"
04/03/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
03/31/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/29/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/02/2023 8-K Quarterly results
Docs: "RenovoRx Reports Full Year 2022 Financial Results and Achievement of Important Phase III Clinical Study Milestone"
02/14/2023 SC 13G/A Agah Ramtin reports a
01/18/2023 8-K Quarterly results
11/22/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
11/22/2022 EFFECT Form EFFECT - Notice of Effectiveness:
11/22/2022 EFFECT Form EFFECT - Notice of Effectiveness:
11/04/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy